首页> 外国专利> A METHOD OF PREVENTION OF LYSOSOMAL LEAKAGE IN EUKARYOTIC CELLS BY USING 6-METHYLURACIL BASED WATER-SOLUBLE COMPOUNDS AND METHOD OF PRODUCING AND USE THEREOF

A METHOD OF PREVENTION OF LYSOSOMAL LEAKAGE IN EUKARYOTIC CELLS BY USING 6-METHYLURACIL BASED WATER-SOLUBLE COMPOUNDS AND METHOD OF PRODUCING AND USE THEREOF

机译:一种基于6-甲基尿嘧啶的水溶性化合物预防真核细胞溶酶体渗漏的方法及其制备和使用方法

摘要

A composition and method of preventing a lysosomal leakage from eukaryotic cells is based on a 6-methyluracil based water-soluble compound. The cells are being exposed to a water solution of such compound for the duration of a sub-optimal condition such as a temperature shock, starvation, radiation, etc. The optimum concentration of the compound is ranging from 1 to 1000 micrograms per milliliter of a solution. The preferred concentration is from 10 to 500 mkg/ml. The most advantageous composition from the group is a complex of 2,4-dihydroxy-6-methylpyrimidine with N-methyl-D-glucamine. Besides cell preservation, the composition is useful for a treatment of a variety of medical conditions characterized by excessive or inappropriate apoptosis such as ischemia, type 1 diabetes, stroke, Alzheimer's, and Parkinson's diseases. The composition is also useful in yeast production, food preservation, and other applications.
机译:防止真核细胞溶酶体渗漏的组合物和方法是基于6-甲基尿嘧啶的水溶性化合物。将细胞暴露于此类化合物的水溶液中,使其处于次优条件下,例如温度冲击,饥饿,辐射等。化合物的最佳浓度范围为1至1000微克/毫升。解。优选的浓度是10至500mkg / ml。该组中最有利的组合物是2,4-二羟基-6-甲基嘧啶与N-甲基-D-葡糖胺的复合物。除了细胞保存之外,该组合物还可用于治疗以过度或不适当的细胞凋亡为特征的多种医学病症,例如缺血,1型糖尿病,中风,阿尔茨海默氏病和帕金森氏病。该组合物也可用于酵母生产,食品保存和其他应用中。

著录项

  • 公开/公告号AU2003263828A1

    专利类型

  • 公开/公告日2004-09-17

    原文格式PDF

  • 申请/专利权人 TECHNOLOGY COMMERCCIALIZATION CORP.;

    申请/专利号AU20030263828

  • 发明设计人 ALEXANDER Y. OKSMAN;

    申请日2003-07-30

  • 分类号A61K31/505;A01N43/54;

  • 国家 AU

  • 入库时间 2022-08-21 23:02:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号